Published in
Springer Nature [academic journals on nature.com], British Journal of Cancer, 9(119), p. 1052-1059, 2018
DOI: 10.1038/s41416-018-0123-9
Links
Tools
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)
Journal article published in 2018 by
Nuria Romero-Laorden 
,
Rebeca Lozano,
Anuradha Jayaram,
Fernando López-Campos,
Maria I. Saez,
Alvaro Montesa,
Ana Gutierrez-Pecharoman,
Rosa Villatoro,
Bernardo Herrera,
Raquel Correa,
Adriana Rosero,
María I. Pacheco,
Teresa Garcés,
Ylenia Cendón ,
Ma Paz Nombela
and other authors.
,
Rebeca Lozano,
Anuradha Jayaram,
Fernando López-Campos,
Maria I. Saez,
Alvaro Montesa,
Ana Gutierrez-Pecharoman,
Rosa Villatoro,
Bernardo Herrera,
Raquel Correa,
Adriana Rosero,
María I. Pacheco,
Teresa Garcés,
Ylenia Cendón ,
Ma Paz Nombela
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 